Who owns VIGIL NEUROSCIENCE?

Tip: Access positions for across all investors

Analyze quarterly positions in Vigil Neuroscience with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vigil Neuroscience stock

Who bought or sold VIGIL NEUROSCIENCE this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Atlas Venture Life Science Advisors 5.8M $23M 0% Jun 2024
 View chart
Northpond Ventures 4.2M $14M 0% Sep 2024
 View chart
Siren 2.0M $6.8M 100% Sep 2024
 View chart
BVF 1.8M $6.2M 0% Sep 2024
 View chart
Sphera Funds Management 1.7M $6.8M -2% Jun 2024
 View chart
Point72 Asset Management 1.6M $5.4M 8% Sep 2024
 View chart
Citadel Advisors 1.4M $4.9M 0% Sep 2024
 View chart
683 Capital Management 1.2M $4.1M 11% Sep 2024
 View chart
Vanguard Group 815k $3.3M -9% Jun 2024
 View chart
Stempoint Capital 744k $2.5M 0% Sep 2024
 View chart
Ensign Peak Advisors 606k $2.1M 53% Sep 2024
 View chart
Deep Track Capital 597k $2.4M -63% Jun 2024
 View chart
Pivotal bioVenture Partners Investment Advisor 561k $1.9M 0% Sep 2024
 View chart
Rock Springs Capital Management 472k $1.9M 0% Jun 2024
 View chart
OrbiMed Advisors 449k $1.5M 0% Sep 2024
 View chart
BlackRock 423k $1.4M 100% Sep 2024
 View chart
BlackRock 405k $1.6M -54% Jun 2024
 View chart
Goldman Sachs Group 401k $1.6M 2099% Jun 2024
 View chart
Arrowpoint Asset Management 290k $984k 0% Sep 2024
 View chart
Standard Life Aberdeen 235k $799k 100% Sep 2024
 View chart
Geode Capital Management 226k $769k 42% Sep 2024
 View chart
Woodline Partners 144k $490k -30% Sep 2024
 View chart
Marshall Wace 144k $490k 100% Sep 2024
 View chart
Bridgeway Capital Management 80k $320k 38% Jun 2024
 View chart
Northern Trust 50k $171k -64% Sep 2024
 View chart
Citigroup 48k $165k 1907% Sep 2024
 View chart
Renaissance Technologies 46k $156k -36% Sep 2024
 View chart
Alpine Partners VI 45k $180k 100% Jun 2024
 View chart
Barclays 45k $152k 0% Sep 2024
 View chart
State Street Corporation 41k $163k -86% Jun 2024
 View chart
Qube Research & Technologies 30k $122k 100% Jun 2024
 View chart
Sherbrooke Park Advisers 26k $90k 100% Sep 2024
 View chart
Bank of America Corporation 24k $80k -12% Sep 2024
 View chart
American Century Companies 20k $68k 100% Sep 2024
 View chart
Morgan Stanley 20k $79k -15% Jun 2024
 View chart
Cubist Systematic Strategies 16k $54k 331% Sep 2024
 View chart
Two Sigma Investments 12k $48k -73% Jun 2024
 View chart
Tower Research Capital 12k $47k 103% Jun 2024
 View chart
Point72 Asia 12k $40k -47% Sep 2024
 View chart
Jump Financial 10k $34k 100% Sep 2024
 View chart
Gotham Asset Management 5.9k $207k 100% Sep 2024
 View chart
Russell Investments 2.0k $8.1k 100% Jun 2024
 View chart
Macquarie Group 831.00 $3.3k 100% Jun 2024
 View chart
Royal Bank of Canada 471.00 $2.0k -98% Sep 2024
 View chart
Jpmorgan Chase & Co 414.00 $1.4k -95% Sep 2024
 View chart
Federated Investors 198.00 $673.002000 0% Sep 2024
 View chart
NISA Investment Advisors 45.00 $153.000000 -40% Sep 2024
 View chart
Point72 7.00 $24.000200 -100% Sep 2024
 View chart

Who sold out of Vigil Neuroscience?

Fund or Company Name Date Sold Shares Held Valued At
Artal Group Jun 2024 1.8M $7.3M
Millennium Management Jun 2024 335k $1.3M
Jane Street Jun 2024 62k $249k
Susquehanna International Jun 2024 48k $192k
Y-Intercept Jun 2024 38k $154k
Centiva Capital Jun 2024 33k $131k
Nuveen Asset Management Mar 2024 27k $92k
Two Sigma Advisers Mar 2024 24k $82k
Sunrise Partners Limited Partnership Jun 2024 17k $66k
Mirae Asset Global Etfs Holdings Jun 2024 8.1k $33k
Acadian Asset Management Jun 2024 6.6k $26k
Rhumbline Advisers Jun 2024 2.6k $10k
New York State Common Retirement Fund Jun 2024 140.00 $1.0k
CWM Jun 2024 16.00 $0